Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Baricitinib

NIAID’s ACTT-2: Hospitalized COVID-19 Patients Fare Better on Lilly’s Baricitinib & Remdesivir vs. Remdesivir Alone: Triggered FDA EUA in Nov. 2020

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), recently produced results […]

NIAID’s ACTT-2 Hospitalized COVID-19 Patients Fare Better on Lilly’s Baricitinib & Remdesivir vs. Remdesivir Alone Triggered FDA EUA in Nov. 2020
2 months ago
Share

Eli Lilly and Company and Incyte Announce Results of Phase 3 Study Using Baricitinib in Combination with Remdesivir

This week, Eli Lilly and Company and Incyte announced the publication of the New England Journal of Medicine’s peer-reviewed results […]

Eli Lilly and Company and Incyte Announce Results of Phase 3 Study Using Baricitinib in Combination with Remdesivir
3 months ago
Share

BenevolentAI Established the Connection: Lilly’s Baricitinib Appears Effective Against COVID-19 in European Clinical Trial

Back in late January, a British artificial intelligence (AI) venture known as BenevolentAI was employed to investigate thousands of potential drug […]

BenevolentAI Established the Connection Lilly’s Baricitinib Appears Effective Against COVID-19 in European Clinical Trial
4 months ago
Share

Lilly Reports Baricitinib Can Improve Conditions of Patients with Severe COVID-19 in Combination with Remdesivir

Eli Lilly recently announced more findings suggesting that it’s rheumatoid arthritis drug called baricitinib could improve the condition of patients […]

Lilly Reports Baricitinib Can Improve Conditions of Patients with Severe COVID-19 in Combination with Remdesivir
5 months ago
Share

Eli Lilly’s Baricitinib Shows Promise as Therapy to Prevent Deadly COVID-19 Cytokine Storms

Four different clinical studies reveal that rheumatoid arthritis drug baricitinib may be effective in preventing cytokine storms—those severe immune system […]

Eli Lilly’s Baricitinib Shows Promise as Therapy to Prevent Deadly COVID-19 Cytokine Storms
8 months ago
Share

Eli Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients

Eli Lilly and Company announced today that the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled […]

Eli Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients
9 months ago
Share

USC Keck Medicine Launches Clinical Trial to Study Baricitinib, an Anti-Inflammatory, as COVID-19 Treatment for Severe Cases

Keck Medicine of USC physicians are launching a clinical trial to evaluate the efficacy and safety of baricitinib, an anti-inflammatory […]

USC Keck Medicine Launches Clinical Trial to Study Baricitinib, an Anti-Inflammatory, as COVID-19 Treatment for Severe Cases
10 months ago
Share

From Computer to Bench to Bedside in A Few Months? AI-Identified Therapy & COVID-19

The first possible treatment of COVID-19 identified by artificial intelligence moves into a randomized controlled trial.  BenevolentAI’s technology has been […]

From Computer to Bench to Bedside in A Few Months AI-Identified Therapy & COVID-19
11 months ago
Share

University of Colorado, Denver Prepares Clinical Trial using Lilly RA Drug to Slow Down or Stop COVID-19-based Severity

The University of Colorado, Denver will launch a clinical trial to evaluate a drug called baricitinib, approved for use in rheumatoid […]

University of Colorado, Denver Prepares Clinical Trial using Lilly RA Drug to Slow Down or Stop COVID-19-based Severity
11 months ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.